Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H26F3N3O2 |
Molecular Weight | 481.5094 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)OC1=CC(CN2CCC(CC2)N3[C@@H](C4=CC=CC=C4)C5=C(NC3=O)C=CC=C5)=CC=C1
InChI
InChIKey=IJUMFEAYOMCXAQ-VWLOTQADSA-N
InChI=1S/C27H26F3N3O2/c28-27(29,30)35-22-10-6-7-19(17-22)18-32-15-13-21(14-16-32)33-25(20-8-2-1-3-9-20)23-11-4-5-12-24(23)31-26(33)34/h1-12,17,21,25H,13-16,18H2,(H,31,34)/t25-/m0/s1
Molecular Formula | C27H26F3N3O2 |
Molecular Weight | 481.5094 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://adisinsight.springer.com/drugs/800022820
Sources: https://adisinsight.springer.com/drugs/800022820
Afacifenacin is being developed by Sumitomo Dainippon Pharma (formerly Dainippon Sumitomo Pharma) and Sunovion Pharmaceuticals as an orally administered therapy for overactive bladder and nocturia. Afacifenacin is a new antimuscarinic that possesses the dual
pharmacological actions of non-selective muscarinic receptor
antagonist and inhibition of the bladder afferent pathway
through sodium-channel blockade. Afacifenacin is in Phase II clinical tirals for the treatment of Nocturia by Nippon Shinyaku.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24899225
Overactive bladder: 20, 40, 80 and 120 mg/day, 8 weeks of treatment
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:42 GMT 2023
by
admin
on
Fri Dec 15 16:11:42 GMT 2023
|
Record UNII |
XQU62QZ74P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000174899
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
42647276
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
C90741
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
DTXSID10236616
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
8791
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
877606-63-8
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545165
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY | |||
|
XQU62QZ74P
Created by
admin on Fri Dec 15 16:11:42 GMT 2023 , Edited by admin on Fri Dec 15 16:11:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |